Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06441136 · ClinicalTrials.gov registry record · NA
Characterizing the Impact of Presbyphonia on Social Interaction
A NA study of Presbyphonia, sponsored by Matthew R. Hoffman.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06441136: Recruiting NA study of Presbyphonia, sponsored by Matthew R. Hoffman.
NCT06441136 is a NA study of Presbyphonia that is actively recruiting participants, run by Matthew R. Hoffman. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06441136, a NA study of Presbyphonia, is actively recruiting participants, sponsored by Matthew R. Hoffman.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if presbyphonia, or voice disorder caused by age-related change in the larynx, is associated with change in social interaction. This proposal investigates the impact of voice impairment in older adults on social interaction, loneliness, social disconnectedness, and depression. A series of questionnaires, voice assessments, and interviews will be performed to improve our understanding of how voice disorders affect older adults and how treatment of voice impairment with voice therapy may improve quality of life.
Primary Outcome
Loneliness will be measured using the University of California - Los Angeles (UCLA) Loneliness Scale questionnaire at baseline and at the end of the 4-week PhoRTE program. The UCLA Loneliness Scale is a 20-item scale with each item rated on a 4-point Likert scale (ranging from 1, "never," to 4, "often") and the total score can range from 20 to 80, with higher scores indicating greater feelings of loneliness.
Conditions Studied
Interventions
- OTHER PhoRTE Program
- OTHER University of California Los Angeles (UCLA) Loneliness Scale
- OTHER Social Disconnectedness Scale
- OTHER Patient Health Questionnaire 9
- OTHER Aging Voice Index
Study Locations (1)
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06441136 shows while recruiting
NCT06441136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Presbyphonia appearing as the primary indexed condition, and to 5 interventions - of which PhoRTE Program is the first listed.
NCT06441136 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06441136 about?
NCT06441136 is a clinical study titled "Characterizing the Impact of Presbyphonia on Social Interaction". The purpose of this study is to determine if presbyphonia, or voice disorder caused by age-related change in the larynx, is associated with change in social interaction. This proposal investigates the impact of voice impairment in older adults on social interaction, loneliness, social disconnectedne...
What is the current status of trial NCT06441136?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-01-10. Estimated completion is 2026-08-31.
What conditions does trial NCT06441136 study?
This clinical trial studies the following conditions: Presbyphonia.
What interventions are being tested in trial NCT06441136?
The interventions under investigation include: PhoRTE Program (OTHER), University of California Los Angeles (UCLA) Loneliness Scale (OTHER), Social Disconnectedness Scale (OTHER), Patient Health Questionnaire 9 (OTHER), Aging Voice Index (OTHER).
Who is sponsoring clinical trial NCT06441136?
This trial is sponsored by Matthew R. Hoffman, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06441136 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06441136's enrollment target sits among peer trials
25 1713th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI